Lexeo Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q3 2023 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Lexeo Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q3 2023 to Q3 2024.
Lexeo Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $8.9M, a 12.7% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$8.9M	-$1.29M	-12.7%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$9.24M			Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$9.56M			Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$9.87M			Dec 31, 2023	10-K	2024-03-11
Q3 2023	$10.2M			Sep 30, 2023	10-Q	2023-12-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.